To further explore the potential value of RFC2 in predicting the prognosis of LGG and other cancers, we analyzed the associations between RFC2 expression and overall survival (OS), disease-specific survival (DSS), disease-free interval (DFI), and progression-free interval (PFI) across cancers in TCGA cohort. The gene discussed is RFC2; the disease is cancer.